Fossil Price Target RAISED and 4 Must-See Stock Analyses

Fossil, Inc. (NASDAQ:FOSL) price target has been raised by Benchmark Co. due to the company’s strong Q2 results, and the firm keeps a Buy rating on the stock.

Express Scripts Inc. (NASDAQ:ESRX): According to Leerink, Express Scripts reported impressive Q2 results and believes the company’s modest accretion guidance for Medco is probably conservative. Leerink stated that it is a buyer of Express Scripts shares, and it keeps an Outperform rating on the stock.

Don’t Miss: How Many NEW iPhones Will Apple Sell? Incorporated (NASDAQ:PCLN) estimates were reduced by Credit Suisse to reflect lowered guidance, but the firm notes that the company keeps gaining share and remains an open-ended growth story. Shares have an Outperform rating.

Black Hills Corporation (NYSE:BKH): According to Credit Suisse, Black Hill’s is one of the most mispriced stocks in the group although management has made efforts to structurally improve the company. Shares have an Outperform rating and a $35 price target.

Orexigen Therapeutics, Inc. (NASDAQ:OREX): Leerink recommends aggressively buying Orexigen shares after the recent weakness and keeps an Outperform rating on the stock after the company’s Q2 results. The firm thinks that Orexigen is making significant pipeline progress with both Contrave and Empatic.

Don’t Miss: Will That Be Debit or Credit? NEITHER.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.